# MACITENTAN
> **ANDA211198** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-04-18
## Drug
- **FDA Application Number:** ANDA211198
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MACITENTAN
- **Generic name:** Macitentan
- **Active ingredients:** MACITENTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA LTD
- **First approval:** 2023-04-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211198)
---
*MORVS · CC0 1.0*